Skip to main content
Clinical Trials/NCT04141527
NCT04141527
Completed
Not Applicable

Spinal Sufentanil for Relief of Labor Pain in Primi- and Multiparous Parturients

Lund University0 sites164 target enrollmentJune 15, 2016
ConditionsLabor Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Labor Pain
Sponsor
Lund University
Enrollment
164
Primary Endpoint
Instrumental delivery
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Background: This descriptive study was designed to evaluate effects and adverse effects of spinal sufentanil for relief of labor pain in primi- and multiparous women.

Methods: The retrospective study design was approved by the regional Human Research Ethics Review Board, Lund, Sweden (Dnr 2015/687). The investigators included 164 (82 primi- and 82 multiparous) obstetrical patients given 10 µg of intrathecal sufentanil for labor pain. Any maternal hypotension, third- or fourth-degree perineal tear, intrapartum Cesarean section, abnormal fetal heart rate, low Apgar score, use of neonatal intensive care, postdural puncture headache, epidural blood patch, and breastfeeding problem was recorded. Major outcome measures were maternal satisfaction with pain relief, and provision of supplementary analgesia.

Detailed Description

A total sample size of 150 parturients had been calculated to enable differences of at least 20 % versus 5.0 % in proportions of obstetrical and neonatal problems between (equal numbers of) primi- and multiparous mothers to be statistically confirmed with 80 % power and 95 % probability. Descriptive parametric data is reported as mean ± standard deviation (SD), and descriptive non-parametric data as median with interquartile range (IQR). Proportions are reported in percent with 95 % confidence interval (CI). Parametric data was compared with two-tailed unpaired student's t-test, and non-parametric data with the Mann-Whitney U-test. Proportions were analyzed with two-tailed Fisher's exact test. Probability (P) values at \< 0.05 were considered statistically significant.

Registry
clinicaltrials.gov
Start Date
June 15, 2016
End Date
June 21, 2017
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Intrathecal sufentanil for labor pain

Exclusion Criteria

  • Demographic, obstetrical or neonatal data is missing

Outcomes

Primary Outcomes

Instrumental delivery

Time Frame: During childbirth

Use of instrumental delivery

Late fetal deceleration

Time Frame: During the first hour after spinal analgesia

FHR(fetal heart rate)\<FHR 40 min beats/ min below the baseline or less than 90/beats min for duration of 2 minutes or more

Supplementary spinal analgesia

Time Frame: 24 hours after initial spinal analgesia

Any use of spinal analgesia after primary spinal analgesia

Maternal hypotension

Time Frame: During the first 20 minutes after spinal analgesia with 5 minutes intervals

Any fall in systolic pressure to \<100 mmHg or a decrease \>20% from the baseline level

Fetal bradycardia

Time Frame: During the first hour after spinal analgesia

A decrease in FHR(fetal heart rate) to 80 beats/ min for duration of 2 or more

Supplementary epidural analgesia

Time Frame: 24 hours after initial spinal analgesia

Any use of epidural analgesia after primary spinal analgesia

Maternal satisfaction with pain relief

Time Frame: 24 hours after spinal analgesia

Defined by parturient after delivery as very god, god, less satisfactory or bad

Postspinal dural puncture headache

Time Frame: 48 hours after spinal analgesia

Rate of postspinal dural puncture headache

Intrapartum Cesarean section

Time Frame: During childbirth

Use of intrapartum Cesarean section

Third- or fourth-degree perineal tear

Time Frame: During childbirth

Rate of third- or fourth-degree perineal tear

Oxytocin before spinal analgesia

Time Frame: 24 hours before childbirth

Any use of oxytocin before spinal analgesia

Oxytocin after spinal analgesia

Time Frame: 24 hours after spinal analgesia

Any use of oxytocin after spinal analgesia

Epidural blood patch

Time Frame: 1 veek after spinal analgesia

Use of epidural blood patch

Secondary Outcomes

  • Breastfeeding(1 week)
  • Time from maternal arrival until request for SA(During childbirth)
  • Time from request for SA until arrival of anaesthesiologist(During childbirth)
  • Time from maximal cervical dilation until delivery(During childbirth)
  • Low Apgar score of newborn (Apgar score ≤ 7 )(One minute and 5 minutes after birth)
  • Use of neonatal intensive care(1 week)
  • Time from arrival of anaesthesiologist until SA(During childbirth)
  • Time from SA until maximal cervical dilation(During childbirth)

Similar Trials